LATUDA
Identification of Latuda
| No description |
Google image searchProduct monograph
Active ingredient
lurasidone hydrochloride, 20 MG
DIN: 02422050
Dosage form(s): TABLET
Route(s) of administration: ORAL
Description: FILM-COATED TABLETS
Schedule: Prescription
Company: SUMITOMO PHARMA CANADA, INC.
Date: 19-JAN-2024
ATC:
- N05 — PSYCHOLEPTICS (ATC, ATC/DDD, )
- N05A — ANTIPSYCHOTICS (ATC, ATC/DDD)
- N05AE — Indole derivatives (ATC, ATC/DDD)
- N05AE05 — LURASIDONE (ATC/DDD)
Reference brand drug: Latuda
